Resultados de búsqueda - Goldin, Mark

Fragmented central venous catheter retained for years with minimal symptoms por Mullan, Clancy W., Tariq, Umair, Goldin, Mark

Enlace del recurso Enlace del recurso Enlace del recurso

Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors por Spyropoulos, Alex C., Giannis, Dimitrios, Goldin, Mark

Enlace del recurso Enlace del recurso Enlace del recurso

Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review por Gianni, Panagiota, Goldin, Mark, Ngu, Sam, Zafeiropoulos, Stefanos, Geropoulos, Georgios, Giannis, Dimitrios

Enlace del recurso Enlace del recurso Enlace del recurso

Impact of recent guideline changes on aspirin prescribing after knee arthroplasty por Shah, Sarav S., Satin, Alexander M., Mullen, James R., Merwin, Sara, Goldin, Mark, Sgaglione, Nicholas A.

Enlace del recurso Enlace del recurso Enlace del recurso

Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China por Shang, Hong, Han, Xiaoxu, Shi, Xuanling, Zuo, Teng, Goldin, Mark, Chen, Dan, Han, Bing, Sun, Wei, Wu, Hao, Wang, Xinquan, Zhang, Linqi

Enlace del recurso Enlace del recurso Enlace del recurso

Comprehensive Analysis of Pathogen-specific Antibody Response in Vivo Based on an Antigen Library Displayed on Surface of Yeast por Zuo, Teng, Shi, Xuanling, Liu, Zhonghua, Guo, Linlin, Zhao, Qing, Guan, Tianxia, Pan, Xianming, Jia, Na, Cao, Wuchun, Zhou, Boping, Goldin, Mark, Zhang, Linqi

Enlace del recurso Enlace del recurso Enlace del recurso

Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH por Spyropoulos, Alex C., Connors, Jean M., Douketis, James D., Goldin, Mark, Hunt, Beverley J., Kotila, Taiwo R., Lopes, Renato D., Schulman, Sam, the International Society on Thrombosis and Haemostasis

Enlace del recurso Enlace del recurso Enlace del recurso

Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19 por Giannis, Dimitrios, Barish, Matthew A., Goldin, Mark, Cohen, Stuart L., Kohn, Nina, Gianos, Eugenia, Chatterjee, Saurav, Lesser, Martin, Coppa, Kevin, Hirsch, Jamie S., McGinn, Thomas, Spyropoulos, Alex C.

Enlace del recurso Enlace del recurso Enlace del recurso

Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19 por Spyropoulos, Alex C., Cohen, Stuart L., Gianos, Eugenia, Kohn, Nina, Giannis, Dimitrios, Chatterjee, Saurav, Goldin, Mark, Lesser, Marty, Coppa, Kevin, Hirsch, Jamie S., McGinn, Thomas, Barish, Matthew A.

Enlace del recurso Enlace del recurso Enlace del recurso

Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients por Cohen, Stuart L., Gianos, Eugenia, Barish, Mathew A., Chatterjee, Saurav, Kohn, Nina, Lesser, Martin, Giannis, Dimitrios, Coppa, Kevin, Hirsch, Jamie S., McGinn, Thomas G., Goldin, Mark E., Spyropoulos, Alex C.

Enlace del recurso Enlace del recurso Enlace del recurso

External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19 por Goldin, Mark, Lin, Stephanie K., Kohn, Nina, Qiu, Michael, Cohen, Stuart L., Barish, Matthew A., Gianos, Eugenia, Diaz, Anise, Richardson, Safiya, Giannis, Dimitrios, Chatterjee, Saurav, Coppa, Kevin, Hirsch, Jamie S., Ngu, Sam, Firoozan, Sheila, McGinn, Thomas, Spyropoulos, Alex C.

Enlace del recurso Enlace del recurso Enlace del recurso

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial por Spyropoulos, Alex C., Goldin, Mark, Ageno, Walter, Albers, Gregory W., Elliott, C. Gregory, Hiatt, William R., Halperin, Jonathan L., Maynard, Gregory, Steg, P. Gabriel, Weitz, Jeffrey I., Spiro, Theodore E., Lu, Wentao, Marsigliano, Jessica, Raskob, Gary E., Barnathan, Elliot S.

Enlace del recurso Enlace del recurso Enlace del recurso

Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older por Ageno, Walter, Lopes, Renato D., Goldin, Mark, Yusen, Roger D., Albers, Gregory W., Elliott, Gregory C., Halperin, Jonathan L., Hiatt, William R., Maynard, Gregory, Steg, Philippe Gabriel, Weitz, Jeffrey I., Suh, Eunyoung, Lu, Wentao, Barnathan, Elliot S., Raskob, Gary E., Spyropoulos, Alex C.

Enlace del recurso Enlace del recurso Enlace del recurso

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The... por Spyropoulos, Alex C., Goldin, Mark, Giannis, Dimitrios, Diab, Wassim, Wang, Janice, Khanijo, Sameer, Mignatti, Andrea, Gianos, Eugenia, Cohen, Marc, Sharifova, Gulru, Lund, Jeet M., Tafur, Alfonso, Lewis, Paul A., Cohoon, Kevin P., Rahman, Husneara, Sison, Cristina P., Lesser, Martin L., Ochani, Kanta, Agrawal, Nirav, Hsia, Judith, Anderson, Victoria E., Bonaca, Marc, Halperin, Jonathan L., Weitz, Jeffrey I.

Enlace del recurso Enlace del recurso Enlace del recurso

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry por Giannis, Dimitrios, Allen, Steven L., Tsang, James, Flint, Sarah, Pinhasov, Tamir, Williams, Stephanie, Tan, Gary, Thakur, Richa, Leung, Christian, Snyder, Matthew, Bhatia, Chirag, Garrett, David, Cotte, Christina, Isaacs, Shelby, Gugerty, Emma, Davidson, Anne, Marder, Galina S., Schnitzer, Austin, Goldberg, Bradley, McGinn, Thomas, Davidson, Karina W., Barish, Matthew A., Qiu, Michael, Zhang, Meng, Goldin, Mark, Matsagkas, Miltiadis, Arnaoutoglou, Eleni, Spyropoulos, Alex C.

Enlace del recurso Enlace del recurso Enlace del recurso